266 related articles for article (PubMed ID: 26541300)
1. Green fabricated reduced graphene oxide: evaluation of its application as nano-carrier for pH-sensitive drug delivery.
Ma N; Zhang B; Liu J; Zhang P; Li Z; Luan Y
Int J Pharm; 2015 Dec; 496(2):984-92. PubMed ID: 26541300
[TBL] [Abstract][Full Text] [Related]
2. Acoustic cavitation induced generation of stabilizer-free, extremely stable reduced graphene oxide nanodispersion for efficient delivery of paclitaxel in cancer cells.
Geetha Bai R; Muthoosamy K; Shipton FN; Manickam S
Ultrason Sonochem; 2017 May; 36():129-138. PubMed ID: 28069192
[TBL] [Abstract][Full Text] [Related]
3. Introducing a highly dispersed reduced graphene oxide nano-biohybrid employing chitosan/hydroxyethyl cellulose for controlled drug delivery.
Mianehrow H; Afshari R; Mazinani S; Sharif F; Abdouss M
Int J Pharm; 2016 Jul; 509(1-2):400-407. PubMed ID: 27286635
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
5. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
Zheng XT; Ma XQ; Li CM
J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
[TBL] [Abstract][Full Text] [Related]
6. Heparin modified graphene oxide for pH-sensitive sustained release of doxorubicin hydrochloride.
Zhang B; Yang X; Wang Y; Zhai G
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():198-206. PubMed ID: 28415455
[TBL] [Abstract][Full Text] [Related]
7. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery.
Miao W; Shim G; Kang CM; Lee S; Choe YS; Choi HG; Oh YK
Biomaterials; 2013 Dec; 34(37):9638-47. PubMed ID: 24016852
[TBL] [Abstract][Full Text] [Related]
8. One-pot synthesis of dextran decorated reduced graphene oxide nanoparticles for targeted photo-chemotherapy.
Hu Y; He L; Ding J; Sun D; Chen L; Chen X
Carbohydr Polym; 2016 Jun; 144():223-9. PubMed ID: 27083812
[TBL] [Abstract][Full Text] [Related]
9. Covalent modification of reduced graphene oxide by means of diazonium chemistry and use as a drug-delivery system.
Wei G; Yan M; Dong R; Wang D; Zhou X; Chen J; Hao J
Chemistry; 2012 Nov; 18(46):14708-16. PubMed ID: 23018420
[TBL] [Abstract][Full Text] [Related]
10. Photoresponsive fluorescent reduced graphene oxide by spiropyran conjugated hyaluronic acid for in vivo imaging and target delivery.
Nahain AA; Lee JE; Jeong JH; Park SY
Biomacromolecules; 2013 Nov; 14(11):4082-90. PubMed ID: 24106989
[TBL] [Abstract][Full Text] [Related]
11. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery.
Hu H; Yu J; Li Y; Zhao J; Dong H
J Biomed Mater Res A; 2012 Jan; 100(1):141-8. PubMed ID: 21997951
[TBL] [Abstract][Full Text] [Related]
12. Chelating ZnO-dopamine on the surface of graphene oxide and its application as pH-responsive and antibacterial nanohybrid delivery agent for doxorubicin.
Alipour N; Namazi H
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110459. PubMed ID: 31924031
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of PEG-functionalized graphene oxide as an effective pH-sensitive drug carrier.
Kazempour M; Namazi H; Akbarzadeh A; Kabiri R
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):90-94. PubMed ID: 30663418
[TBL] [Abstract][Full Text] [Related]
14. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
[TBL] [Abstract][Full Text] [Related]
15. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
Shim G; Kim JY; Han J; Chung SW; Lee S; Byun Y; Oh YK
J Control Release; 2014 Sep; 189():80-9. PubMed ID: 24973719
[TBL] [Abstract][Full Text] [Related]
16. Nano-biointeractions of PEGylated and bare reduced graphene oxide on lung alveolar epithelial cells: A comparative in vitro study.
Reshma SC; Syama S; Mohanan PV
Colloids Surf B Biointerfaces; 2016 Apr; 140():104-116. PubMed ID: 26741270
[TBL] [Abstract][Full Text] [Related]
17. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide.
Kim H; Lee D; Kim J; Kim TI; Kim WJ
ACS Nano; 2013 Aug; 7(8):6735-46. PubMed ID: 23829596
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled graphene-dextran nanohybrid for killing drug-resistant cancer cells.
Jin R; Ji X; Yang Y; Wang H; Cao A
ACS Appl Mater Interfaces; 2013 Aug; 5(15):7181-9. PubMed ID: 23875578
[TBL] [Abstract][Full Text] [Related]
19. Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells.
Imani R; Shao W; Taherkhani S; Emami SH; Prakash S; Faghihi S
Colloids Surf B Biointerfaces; 2016 Nov; 147():315-325. PubMed ID: 27543693
[TBL] [Abstract][Full Text] [Related]
20. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel.
Xu Z; Wang S; Li Y; Wang M; Shi P; Huang X
ACS Appl Mater Interfaces; 2014 Oct; 6(19):17268-76. PubMed ID: 25216036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
